Source: International Congress 2019 – The changing face of rare diffuse parenchymal lung diseases: recent advances in pathogenesis, clinical manifestations and treatment
Disease area: Interstitial lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
A. Tazi (Paris, France), E. Bugnet (Paris, France), N. Gupta (Cincinnati, United States of America), G. Lorillon (Paris, France), S. Arbabzadeh-Bouchez (Paris, France), J. Lépine (Paris, France), S. Chevret (Paris, France). Psychological abnormalities are commonly present in adult patients with pulmonary Langerhans cell histiocytosis. 1404

Member's Comments

No comment yet.

Related content which might interest you: Clinical features and outcome of adult patients with pulmonary Langerhans cell histiocytosis Source: International Congress 2019 – Innovative approaches for management and treatment of rare diffuse parenchymal lung diseases Year: 2019 Chemotherapy in patients with pulmonary Langerhans cell histiocytosis Source: International Congress 2018 – Progress in rare interstitial lung diseases Year: 2018 Pulmonary Langerhans' cell histiocytosis Source: Respipedia Article Year: 2016 How I manage pulmonary Langerhans cell histiocytosis Source: Eur Respir Rev, 26 (145) 170070; 10.1183/16000617.0070-2017 Year: 2017 Paediatric pulmonary Langerhans cell histiocytosis Source: Breathe, 16 (2) 200003; 10.1183/20734735.0003-2020 Year: 2020 Clinical and pathological features of 13 adult patients with pulmonary Langerhans‘ cell histiocytosis Source: Annual Congress 2009 - Clinical aspects of diffuse parenchymal lung disease Year: 2009 Pulmonary Langerhans‘ cell histiocytosis (PLCH). Report of two cases diagnosed with pulmonary vascular involvement via exercise tests Source: Annual Congress 2008 - Miscellaneous aspects of interstitial lung disease Year: 2008 Pneumothorax in patients with Langerhans cell histiocytosis Source: International Congress 2017 – The acute patient: the clinical point-of-view Year: 2017 Exercise in patients with pulmonary Langerhans cell histiocytosis: performance and mechanisms of limitation Source: International Congress 2017 – From idiopathic pulmonary fibrosis (IPF) to rare diseases Year: 2017 Genetic landscape of adult Langerhans cell histiocytosis with lung involvement Source: Eur Respir J, 55 (2) 1901190; 10.1183/13993003.01190-2019 Year: 2020 Clinical study of pulmonary hypertension complicating pulmonary Langerhans cell histiocytosis Source: Annual Congress 2012 - Diffuse parenchymal lung disease I Year: 2012 Clinical impact of BRAFV600E mutation in adult pulmonary Langerhans cell histiocytosis Source: International Congress 2019 – Towards a better understanding of rare diffuse parenchymal lung diseases Year: 2019 Ventilation disorders dynamics and morphological changes in patients with pulmonary Langerhans cell histiocytosis (PLCH) Source: International Congress 2015 – IIPs: orphan Year: 2015 Pulmonary Langerhans‘ cell histiocytosis Source: Eur Respir J 2006; 28: Suppl. 50, 826s Year: 2006 Pulmonary Langerhans cell histiocytosis Source: Annual Congress 2008 - PG5 - Interstitial lung diseases: selected orphan diseases Year: 2008 Pulmonary Langerhans' cell histiocytosis Source: Eur Respir Mon; 2009: 46: 155–175 Year: 2009 Pneumothorax in pulmonary langerhans cell histiocytosis (PLCH) Source: International Congress 2018 – New insights in rare diffuse parenchymal lung diseases (DPLDs) in adults and children Year: 2018 Pulmonary hypertension in pulmonary Langerhans’ cell histiocytosis Source: Eur Respir Mon 2012; 57: 161-165 Year: 2012 Langerhans cell histiocytosis: is it an ILD? Source: Virtual Congress 2021 – Interstitial lung diseases Year: 2021